Abstract
BACKGROUND. Nuclear factor-κB (NF-κB), a key transcription factor thought to play a major role in carcinogenesis, regulates many important signaling pathways involved in tumor promotion. Although NF-κB can be activated in lung cancer cell lines by tobacco exposure, there have been no studies of the expression of NF-κB in lung cancer pathogenesis. METHOOS. The immunohistochemical expression of NF-κB p65 was investigated in 394 lung cancers (370 nonsmall cell lung carcinomas [NSCLC]; and 24 small cell lung carcinomas [SCLC]) and 269 lung normal epithelium and preneoplastic lesions, including hyperplasias, squamous metaplasias, dysplasias, and atypical adenomatous hyperplasias. RESULTS. High levels of nuclear immunohistochemical expression of NF-κB p65 were detected in the lung cancers, with significantly higher levels in SCLCs compared with NSCLCs (P < .0001). In adenocarcinomas the NF-κB p65 expression level was significantly higher in advanced TNM stages (III-IV) than in earlier stages (I-II) (P < .0001), and when NF-κB p65 is dichotomized using 50% as the cutoff point (high vs low), a higher NF-κB p65 expression level was detected in tumors having either K-RAS (P = .02) or EGFR (P = .009) mutations compared with wildtype tumors. A relatively high level of nuclear NF-κB p65 expression was detected in normal and mildly abnormal epithelium, and a progression with increasing histology severity was detected in preneoplastic lesions. CONCLUSIONS. NF-κB p65 nuclear expression is an early and frequent phenomenon in the pathogenesis of lung cancer. The findings indicate that NF-κB activation plays an important role in lung cancer pathogenesis and is a suitable target for the development of new lung cancer therapies and chemoprevention strategies.
Original language | English (US) |
---|---|
Pages (from-to) | 2637-2646 |
Number of pages | 10 |
Journal | Cancer |
Volume | 107 |
Issue number | 11 |
DOIs | |
State | Published - Dec 1 2006 |
Keywords
- EGFR mutation
- Inflammation
- K-RAS mutation
- Lung cancer
- Lung preneoplasia
- Nf-κB
- Squamous dysplasia
ASJC Scopus subject areas
- Oncology
- Cancer Research